Hensoldt's €10.4 Billion Backlog Puts the Spotlight on One Number
Published on 08/15/2026 at 05:48 | Redaktion boerse-global.de
The defense electronics group has spent the past month riding a wave of geopolitical tension, sector-wide momentum, and a record order intake that has reshaped the conversation around its growth trajectory. But as the shares settle near €95.72 — up 30 percent in 30 days — the debate among analysts has narrowed to a single, decisive metric: how much of that backlog is actually convertible into future revenue.
That question carries particular weight given the scale of what Hensoldt reported in late July. Half-year sales climbed 24 percent to €1.17 billion, with adjusted EBITDA up 29 percent to €137 million. The second quarter alone saw revenue rise 22 percent to €671 million and adjusted EBITDA reach €93 million. More striking, however, was the order intake: it nearly doubled to €2.81 billion in the first half, and the Q2 figure alone jumped 89 percent to €1.33 billion. The cumulative effect pushed the order book to a record €10.36 billion — a cushion that, on paper, gives the company years of revenue visibility.
Speaking of managing risk and long-term planning — the same discipline applies to workplace safety. Many employers underestimate the gaps in their risk documentation until an incident forces the issue. A free toolkit with 41 ready-to-use templates and checklists helps you document hazards properly and stay compliant. Download the free Risk Assessment Toolkit
The 3.7x Question
Warburg analyst Christian Cohrs has framed the key test in stark terms: the backlog now stands at 3.7 times the revenue expected for 2026, when management forecasts sales of roughly €2.75 billion. That ratio is the foundation on which the bull case rests. As long as it holds — or improves — Hensoldt can argue for richer valuation multiples. If order intake falters or program timelines slip, the logic underpinning the rally begins to erode.
Cohrs has nonetheless cautioned that the extraordinary Q2 effects should be treated as temporary, even as he raised his price target. That measured tone stands in contrast to the more enthusiastic read from Deutsche Bank, which on Thursday lifted its target from €98.80 to €105 and reaffirmed a "Buy" rating. JPMorgan's David Perry also moved his target higher — from €85 to €100 — but left the stock at "Neutral," a signal that even growth-friendly houses see limited upside at current levels.
A Rally With Multiple Drivers
The recent share-price surge is not purely a Hensoldt story. Friday's gains came amid a broad defense-sector advance, triggered by fresh US sanctions on Iran and a naval blockade in the Strait of Hormuz. Sector-wide sentiment also got a lift from Bernstein Research's upgrade of competitor TKMS, which dragged the entire group higher. Reports of French acquisition activity and an upcoming NATO summit in Ankara, where billions in military aid for Ukraine are expected to be pledged, have added further tailwinds.
Hensoldt has also been building its own momentum on the operational front. The Federal Office of Bundeswehr Equipment, Information Technology and In-Service Support has awarded the company a series-production contract for equipping dismounted Joint Fire Support Teams, including software integration for Digitally Aided Close Air Support. Separately, the company plans a new development center in Leinfelden near Stuttgart focused on "Software-Defended Defence," with around 300 positions, supported by a cooperation agreement with Bosch to lease space and bring in skilled workers from the automotive sector.
Management has also held firm on its 2026 guidance — roughly €2.75 billion in revenue and an adjusted EBITDA margin between 18.5 and 19 percent — despite losing the F126 frigate program. That resilience suggests the backlog can absorb individual program losses, a point that bolsters the structural growth narrative.
The Other Side of the Ledger
The bear case is not hard to construct. Jefferies removed its buy recommendation in early August, offering a counterpoint to the broader analyst enthusiasm. The stock now trades well above its moving averages, a technical condition that historically signals overbought territory and raises the risk of a pullback if geopolitical tensions ease. The F126 loss is a reminder that even a record order book does not immunize the company against program cancellations.
Should the situation in the Strait of Hormuz de-escalate, a portion of the recent gains — which have been heavily driven by sector sentiment and headline risk — could unwind just as quickly as they appeared.
What Comes Next
The market capitalization has reached €10.75 billion, and the shares sit roughly 19 percent below their 52-week high of €117.70, set in early October. The June low of €63.12 now feels distant, but the distance between the current price and that high leaves room for debate about whether the stock is fully valued or still catching up.
The next concrete test will come with the upcoming quarterly reports, when investors will see whether order intake can sustain its record pace or whether the recent surge was, at least in part, a function of exceptional circumstances. For now, the structural argument remains intact — but the valuation debate is far from settled.
